FONT-SIZE Plus   Neg

TCP Prices IPO For Proceeds Of $85 Mln.

TCP Capital Corp. (TCPC) Wednesday priced its IPO at $14.75 for an aggregate proceeds of about $85 million from its initial public offering. The investment company's stock dropped nearly four percent on the first day of trading, on broad market trends.

TCP Capital priced its IPO of 5.75 million shares at $14.75 per share, to raise $84.8 million. TCP plans to use the proceeds to repay outstanding debt under its credit facility and on investments.

The company has also granted underwriters a 30-day option to buy up to 863 thousand additional shares to cover over-allotments. Deutsche Bank Securities Inc. and Stifel, Nicolaus & Co. Inc are the joint book-running managers, with Oppenheimer & Co. Inc. as lead manager.

The company's stock is listed on the Nasdaq Global Select Market under the symbol TCPC. The shares are expected to be delivered on April 10, 2012.

TCP Capital is a business development company externally managed by Tennenbaum Capital Partners LLC. TCP Capital primarily invests in debt securities of middle-market companies, or enterprise worth between $100 million and $1.5 billion.

Tennenbaum Capital is a investment management firm focused primarily on special situation credit investments, and has invested over $10 billion in over 200 companies.

TCP Capital also declared a second quarter cash dividend of $0.34 per share, payable on June 29 to stockholders as of June 15.

TCPC is currently trading on the Nasdaq at $14.30, down 3.05%, on a volume of 1.3 million shares.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Electric car maker Tesla Motors Inc. (TSLA), Wednesday reported a profit for the third quarter beating Wall Street estimates by a large margin, driven primarily by record production and deliveries. Shares of the company gained over 5 percent in extended hours after the company reaffirmed its delivery... Auvi-Q, the rival for EpiPen, will be coming back in 2017, pharmaceutical company Kaleo announced on Wednesday. Auvi-Q is a epinephrine injection used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions. Auvi-Q... Uber's self-driving technology start-up Otto has partnered with Anheuser-Busch InBev to complete the world's first shipment by a self-driving truck. Otto said in a blog post that the company and Anheuser-Busch delivered 51,744 cans of Budweiser beer from Fort Collins, through downtown Denver, to Colorado Springs.
comments powered by Disqus
Follow RTT